NCT00023231 - Pediatric Kidney Transplant Without Calcineurin Inhibitors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2006

Conditions

End-Stage Renal Disease

Interventions

DRUG

Daclizumab

1 mg/kg/dose at study entry and Weeks 2, 4, 6, and 8

DRUG

Methylprednisolone/prednisone

Dosage is dependent on weight and varies throughout study. Refer to protocol for more information.

DRUG

Mycophenolate mofetil

Solution or oral tablet taken daily. Dosage depends on body surface area.

DRUG

Sirolimus

Oral tablet taken once prior to transplant. Dosage dependent on body surface area.

DRUG

Bactrim

Oral tablet taken three times per week. Dosage is dependent on weight.

DRUG

Ganciclovir

Oral tablet taken daily. Dosage is dependent on weight.

DRUG

Lipitor

Oral tablet taken daily

Trial Locations (1)

Lauren Schenker, Rockville

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH